CVET Covetrus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CVET

Price (delayed)

$19.15

Market cap

$2.64B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$3.48B

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. The company is bringing together products, services, and technology into ...

Highlights
Covetrus's EPS has soared by 91% YoY
The net income has soared by 91% YoY
CVET's quick ratio is down by 12% year-on-year and by 2.5% since the previous quarter
CVET's gross margin is down by 2.1% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: http://www.covetrus.com
Peers: IDXX

Key stats

What are the main financial stats of CVET
Market
Shares outstanding
137.62M
Market cap
$2.64B
Enterprise value
$3.48B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.74
Price to sales (P/S)
0.58
EV/EBIT
N/A
EV/EBITDA
22.57
EV/Sales
0.77
Earnings
Revenue
$4.54B
EBIT
-$42M
EBITDA
$154M
Free cash flow
-$60M
Per share
EPS
-$0.71
Free cash flow per share
-$0.44
Book value per share
$11
Revenue per share
$33.13
TBVPS
$12.72
Balance sheet
Total assets
$3.41B
Total liabilities
$1.89B
Debt
$1.07B
Equity
$1.5B
Working capital
$710M
Liquidity
Debt to equity
0.71
Current ratio
2
Quick ratio
1.17
Net debt/EBITDA
5.46
Margins
EBITDA margin
3.4%
Gross margin
18.4%
Net margin
-1.9%
Operating margin
-1.3%
Efficiency
Return on assets
-2.5%
Return on equity
-5.8%
Return on invested capital
-2.2%
Return on capital employed
-1.6%
Return on sales
-0.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CVET stock price

How has the Covetrus stock price performed over time
Intraday
-0.05%
1 week
-2.25%
1 month
-12.68%
1 year
-16.67%
YTD
-33.37%
QTD
-29.07%

Financial performance

How have Covetrus's revenue and profit performed over time
Revenue
$4.54B
Gross profit
$833M
Operating income
-$58M
Net income
-$86M
Gross margin
18.4%
Net margin
-1.9%
Covetrus's operating margin has surged by 95% YoY but it has decreased by 8% QoQ
CVET's operating income has soared by 94% year-on-year but it is down by 9% since the previous quarter
The net margin has soared by 92% YoY
The net income has soared by 91% YoY

Growth

What is Covetrus's growth rate over time

Valuation

What is Covetrus stock price valuation
P/E
N/A
P/B
1.74
P/S
0.58
EV/EBIT
N/A
EV/EBITDA
22.57
EV/Sales
0.77
Covetrus's EPS has soared by 91% YoY
The P/B is 28% below the last 4 quarters average of 2.4
The company's equity rose by 18% YoY
The P/S is 28% less than the last 4 quarters average of 0.8
Covetrus's revenue has increased by 10% YoY and by 3.7% from the previous quarter

Efficiency

How efficient is Covetrus business performance
Covetrus's ROS has plunged by 200% from the previous quarter but it has soared by 96% YoY
The company's return on invested capital has shrunk by 200% QoQ but it has surged by 96% YoY
The return on equity has surged by 92% year-on-year
The ROA has soared by 91% YoY

Dividends

What is CVET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVET.

Financial health

How did Covetrus financials performed over time
CVET's total assets is 81% greater than its total liabilities
CVET's quick ratio is down by 12% year-on-year and by 2.5% since the previous quarter
Covetrus's total liabilities has decreased by 5% YoY
The debt is 29% less than the equity
The debt to equity has declined by 19% year-on-year
The company's equity rose by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.